We've performed more than 14,000 bone marrow and stem cell transplants with unparalleled survival rates for 13 consecutive years.
City of Hope conducts 500 clinical trials each year, enrolling more than 6,200 patients.
City of Hope researchers are investigating ways immunotherapy (harnessing the body's natural defenses to fight cancer) can be used to fight lymphoma and melanoma by shutting off a gene that promotes cancer while stimulating the immune system to act.
By investigating the molecular mechanisms of diabetes complications, City of Hope scientists are helping develop new treatments for them.
Based on technology pioneered by City of Hope, breakthrough cancer drugs including Herceptin, Erbitux, Rituxan and Avastin are saving lives worldwide.
We hold more than 300 patents and submit nearly 30 applications per year to the Food and Drug Administration for investigational new therapies.
A City of Hope partnership with Translational Genomics Research Institute will accelerate the speed with which research discoveries are converted into cures.
We are the only comprehensive cancer center with four FDA-approved manufacturing facilities for small molecules, biologics, stem cells and radiopharmaceuticals where researchers can quickly test, refine and create new drugs and therapies for clinical use.